In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on Magenta Therapeutics (MGTA), with a price target of ...
The post Magenta Therapeutics (MGTA) Gets a Buy Rating from Mizuho Securities appeared first on Smarter Analyst.
In a report released today, Difei Yang ...

https://www.smarteranalyst.com/new-blurbs/magenta-therapeutics-mgta-gets-a-buy-rating-from-mizuho-securities/

#SmarterAnalyst